Siga Technologies (SIGA) Revenue Growth (1y) (2011 - 2025)
Powered by 
Analysis
Siga Technologies (SIGA) Revenue Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 6.60% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 10.16% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 5.07% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 2.52% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 2.60% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 19.16% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 37.72% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | -1.92% |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -73.83% |
| Jun 30, 2025 | 271.92% |
| Mar 31, 2025 | -72.31% |
| Dec 31, 2024 | -30.06% |
| Sep 30, 2024 | 8.39% |
| Jun 30, 2024 | 271.05% |
| Mar 31, 2024 | 205.54% |
| Dec 31, 2023 | 925.53% |
| Sep 30, 2023 | -87.21% |
| Jun 30, 2023 | -64.73% |
| Mar 31, 2023 | -21.03% |
| Dec 31, 2022 | -90.15% |
| Sep 30, 2022 | 1,390.07% |
| Jun 30, 2022 | 92.61% |
| Mar 31, 2022 | 118.94% |
| Dec 31, 2021 | 205.75% |
| Sep 30, 2021 | -89.05% |
| Jun 30, 2021 | -78.55% |
| Mar 31, 2021 | 83.75% |
| Dec 31, 2020 | 784.83% |